Abstract

Dry cow antibiotic therapy is used to eliminate existing intramammary infections and to prevent new infections in the dry period. It is implemented as part of a total management system known as the 'Five-Point Plan' for mastitis control. Recent public concerns over the widespread prophylactic use of antibiotics, coupled with an increasing interest in organic farming, have lead to a re-evaluation of the treatment of cows at drying-off. As a result, attention has focussed on the use of novel alternatives to antibiotic therapy at the end of lactation. One such therapy involves the application of a non-antibiotic bismuth-based intramammary teat seal designed for use in cows with low cell counts at the end of lactation. Like the keratin plug that forms naturally in teats of cows that have been dried-off, teat seal forms a physical barrier to invading pathogens. To date, a number of independent studies have shown that teat seal is as effective as traditional dry cow antibiotic products in preventing the occurrence of new infection during the dry period in cows with somatic cell counts of ≤200,000 cells ml-1 at drying-off. This paper reviews the efficacy of teat seal in preventing dry period mastitis in both conventional and organic dairying systems.

Highlights

  • Mastitis continues to be one of the greatest problems faced by the dairy industry

  • About 20 to 35% of clinical mastitis cases are of unknown aetiology (Wellenberg et al, 2002), it is widely accepted that bovine mastitis is mainly bacterial in origin

  • Tel: +353 25 42285 Fax: +353 25 42340 E-mail: bmeaney@moorepark.teagasc.ie dry cow therapy days in milking generally regarded as safe somatic cell count teat seal peer reviewed until the 1960s, following the introduction of a ‘Five-Point Plan’ developed initially in the UK (Smith et al, 1967), that any success was achieved in the control of clinical and subclinical mastitis (Berry and Hillerton, 2002a)

Read more

Summary

Key words

Mastitis, Dry cow therapy, Antibiotics, Dry cow antibiotic therapy is used to eliminate existing intramammary infections and to prevent new Teat seal. Attention has focussed on the use of novel alternatives to antibiotic therapy at the end of lactation. One such therapy involves the application of a non-antibiotic bismuth-based intramammary teat seal designed for use in cows with low cell counts at the end of lactation. A number of independent studies have shown that teat seal is as effective as traditional dry cow antibiotic products in preventing the occurrence of new infection during the dry period in cows with somatic cell counts of ≤200,000 cells ml-1 at drying-off. This paper reviews the efficacy of teat seal in preventing dry period mastitis in both conventional and organic dairying systems

TS teat seal
All major pathogens
New IMI at calving
Discussion
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call